We invest exclusively in new ventures operating within the $3.5 trillion U.S. Healthcare industry. We invest in companies that are both innovative and have the ability to meaningfully contribute to healthcare cost reduction. Example sectors include:

  • Medical technologies
  • Biotechnology
  • Healthcare services
  • Healthcare IT
  • Healthcare enabled AI/ML


We are early-stage venture investors, often being the first round or institutional round of financing. We generally enter between Seed – Series B, and to date have created many of the companies we have exited or are currently invested in. We will opportunistically invest in later stage deals provided they fit other modalities important to us.


We generally invest between $2-10 million per round, and target $8-20 million in total capital invested over the life of a company, but are flexible based on the needs of the company. We have both worked with a variety of syndicate partners, but are also comfortable leading rounds ourselves. We typically serve on the board of directors of our portfolio companies and strive to maintain our position as lead or co-lead in supporting the firm with its goals.


Santé maintains offices in Austin and Houston. We invest in companies headquartered in the United States.

March 18, 2020 NewLink Genetics Stockholders Approve Merger with Lumos Pharma
Read More
February 25, 2020 BioStable Science & Engineering Announces Initial Closing of Series C Equity Round
Read More